NCT02276118

Brief Summary

Recently, E.Motion-PS-Pro (B.Braun-Aesculap, Tuttlingen, Germany), a new mobile bearing knee system with a unique ball and socket post-cam mechanism was developed for use in total knee arthroplasty. This study aims to determine (1) whether the use of E.Motion-PS-Pro improves prosthesis fitness for the femur and tibia in terms of under- or over-hang incidence compared to an established successful prosthesis, Genesis II (Smith \& Nephew, Memphis, U.S.A.), (2) whether patients with this new prosthesis experience less pain and faster wound healing in early recovery phase, (3) whether patients with E.Motion-Pro reach functional plateaus faster than patients with Genesis II and the functional plateaus of patients with E.Motion-Pro are higher than those of patients with Genesis II.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2014

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

October 19, 2014

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 27, 2014

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

October 27, 2014

Status Verified

July 1, 2014

Enrollment Period

1 year

First QC Date

October 19, 2014

Last Update Submit

October 23, 2014

Conditions

Outcome Measures

Primary Outcomes (5)

  • prosthesis fit

    Component fitness will be evaluated by whether there is overhang (too wide or big) or underhang (too narrow or small) more than 2 mm at any of three sites: condyle, junction, and anterior flange

    from the start to end of surgery (expected average of 90 minutes)

  • pain level during gait at 3 months after surgery

    Pain levels will be evaluated by asking how much pain patients feel during weight bearing gait at 3 months in 0-10 visual analog scale (0-no pain and 10-maximum pain)

    at 3 months after surgery

  • knee swelling (circumference measured at the knee) at 3 months

    Knee swelling will be evaluated by measuring the leg circumference at the knee level (mid-patella), and the measured circumference will be compared with the preoperative circumference

    at 3 months after surgery

  • flexion contracture and maximum flexion at 3 months

    Flexion contracture and further flexion will be measured by a single investigator using a 38-cm clinical goniometer with patients supine

    at 3 months after surgery

  • the new American Knee Society (AKS) score at 6 months

    Patients will be evaluated at 6 months using the new scoring system of American Knee Society. The American Knee Society scoring system evaluates multiple aspects of outcomes: 1) Objective knee indicators (maximum points 80) - alignment (25), mediolateral (ML) stability (15), anteroposterior (AP) stability (10), range of motion (ROM) (30); 2) Knee score (maximum points 80) - symptoms (25), patient satisfaction (40), and expectation (15); 3) Function score (maximum points 100) - walking \& standing (30), standard activities (30), advanced activities (25), discretionary knee activities (15)

    at 6 months after surgery

Secondary Outcomes (10)

  • whether balanced gaps were achieved

    from the start to end of surgery (expected average of 90 minutes)

  • tourniquet time

    from the start to end of surgery (expected average of 90 minutes)

  • blood volume drained via a vacuum drainage in the subcutaneous tissue

    from the end of surgery to removal of vacuum drainage (usually at 2 days after surgery)

  • hemoglobin drop on postoperative 2 and 5 days

    at 2 and 5 days after surgery

  • pain level during motion arc exercise at 2 and 6 weeks

    at 2 and 6 weeks after surgery

  • +5 more secondary outcomes

Study Arms (2)

e.motion PS Pro group

EXPERIMENTAL

the patients who receives total knee arthroplasty with the e.motion PS pro prosthesis

Device: device: e.motion PS Pro

Genesis II group

ACTIVE COMPARATOR

the patients who receives total knee arthroplasty with the Genesis II prosthesis

Device: device : Genesis II

Interventions

patients will undergo total knee arthroplasty with e.motion PS Pro implant

e.motion PS Pro group

patients will undergo total knee arthroplasty with Genesis II implant

Genesis II group

Eligibility Criteria

AgeUp to 79 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • patients who are decided to undergo total knee arthroplasty with diagnosis of primary osteoarthritis

You may not qualify if:

  • the diagnosis other than primary osteoarthritis
  • previous history of infection or trauma requiring surgical treatment on the knee which will receive total knee arthroplasty
  • patients of 80 years or older
  • patients with systemic diseases that can affect functional outcomes of TKA

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Joint Reconstruction Center, Seoul National University Bundang Hospital

Seongnam-si, Gyeonggi-do, 463-707, South Korea

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Tae Kyun Kim, MD, PhD

    Seoul National University Bundang Hospital

    STUDY CHAIR

Central Study Contacts

Tae Kyun Kim, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 19, 2014

First Posted

October 27, 2014

Study Start

July 1, 2014

Primary Completion

July 1, 2015

Study Completion

December 1, 2015

Last Updated

October 27, 2014

Record last verified: 2014-07

Locations